243 related articles for article (PubMed ID: 9647234)
21. A two-step mechanism for recruitment of Pip by PU.1.
Perkel JM; Atchison ML
J Immunol; 1998 Jan; 160(1):241-52. PubMed ID: 9551977
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of c-fos overexpression on B cell proliferative responses to membrane IGM cross-linking.
Tomita Y; Koizumi T; Mizuno K; Tokuhisa T
Kobe J Med Sci; 1995 Oct; 41(5):141-53. PubMed ID: 8929635
[TBL] [Abstract][Full Text] [Related]
23. Cloning of the murine CD5 promoter and its tissue-specific regulation.
Weichert TR; Schwartz RC
J Immunol; 1995 May; 154(9):4603-12. PubMed ID: 7536775
[TBL] [Abstract][Full Text] [Related]
24. Normal B-1a cell development requires B cell-intrinsic NFATc1 activity.
Berland R; Wortis HH
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13459-64. PubMed ID: 14595020
[TBL] [Abstract][Full Text] [Related]
25. PMA/ionomycin induces Ig kappa 3' enhancer activity which is in part mediated by a unique NFAT transcription complex.
Meyer KB; Ireland J
Eur J Immunol; 1998 May; 28(5):1467-80. PubMed ID: 9603451
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the expression and gene promoter of CD22 in murine B cells.
Andersson KB; Draves KE; Magaletti DM; Fujioka S; Holmes KL; Law CL; Clark EA
Eur J Immunol; 1996 Dec; 26(12):3170-8. PubMed ID: 8977319
[TBL] [Abstract][Full Text] [Related]
27. Inducible nuclear factors binding the IgM heavy chain pre-mRNA secretory poly(A) site.
Phillips C; Schimpl A; Dietrich-Goetz W; Clements JB; Virtanen A
Eur J Immunol; 1996 Dec; 26(12):3144-52. PubMed ID: 8977316
[TBL] [Abstract][Full Text] [Related]
28. Diverse transcription factors are involved in the quantitative regulation of transcriptional activation of kappa promoters.
Bemark M; Leanderson T
Eur J Immunol; 1997 Jun; 27(6):1308-18. PubMed ID: 9209478
[TBL] [Abstract][Full Text] [Related]
29. HMG box-activating factors 1 and 2, two HMG box transcription factors that bind the human Ig heavy chain enhancer.
Stevens S; Ordentlich P; Sen R; Kadesch T
J Immunol; 1996 Oct; 157(8):3491-8. PubMed ID: 8871648
[TBL] [Abstract][Full Text] [Related]
30. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
Cambier JC; Monroe JG
J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
[TBL] [Abstract][Full Text] [Related]
31. Unusual Rel-like architecture in the DNA-binding domain of the transcription factor NFATc.
Wolfe SA; Zhou P; Dötsch V; Chen L; You A; Ho SN; Crabtree GR; Wagner G; Verdine GL
Nature; 1997 Jan; 385(6612):172-6. PubMed ID: 8990122
[TBL] [Abstract][Full Text] [Related]
32. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
Cheng YH; Handwerger S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
[TBL] [Abstract][Full Text] [Related]
33. Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization.
Johnson BV; Bert AG; Ryan GR; Condina A; Cockerill PN
Mol Cell Biol; 2004 Sep; 24(18):7914-30. PubMed ID: 15340054
[TBL] [Abstract][Full Text] [Related]
34. Segmental regulation of Hoxb-3 by kreisler.
Manzanares M; Cordes S; Kwan CT; Sham MH; Barsh GS; Krumlauf R
Nature; 1997 May; 387(6629):191-5. PubMed ID: 9144291
[TBL] [Abstract][Full Text] [Related]
35. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
Hamano T; Leiserson WM; Asofsky R
J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
[TBL] [Abstract][Full Text] [Related]
36. Activator proteins which regulate immunoglobulin heavy chain gene transcription in B lymphocytes.
Roman C; Riggs K; Merrell K; Calame K
Prog Clin Biol Res; 1990; 352():241-8. PubMed ID: 2119507
[TBL] [Abstract][Full Text] [Related]
37. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
Teutsch M; Higer M; Wang D; Wortis HW
Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861
[TBL] [Abstract][Full Text] [Related]
38. Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells.
Chen U; Scheuermann RH; Wirth T; Gerster T; Roeder RG; Harshman K; Berger C
Nucleic Acids Res; 1991 Nov; 19(21):5981-9. PubMed ID: 1658749
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional analysis of inhibition of lipopolysaccharide response by anti-IgM.
Moore BB; Ariizumi K; Tucker PW; Yuan D
J Immunol; 1993 Apr; 150(8 Pt 1):3366-74. PubMed ID: 8468476
[TBL] [Abstract][Full Text] [Related]
40. Roles of Ets proteins, NF-kappa B and nocodazole in regulating induction of transcription of mouse germline Ig alpha RNA by transforming growth factor-beta 1.
Shi MJ; Park SR; Kim PH; Stavnezer J
Int Immunol; 2001 Jun; 13(6):733-46. PubMed ID: 11369700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
